Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Organocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel synthesis of chiral binaphthyl-aza ligands from patent CN112142638A. Achieve high enantioselectivity with scalable, cost-effective manufacturing processes.
Patent CN111763157B reveals a novel one-step asymmetric synthesis for chiral amino compounds, enabling cost reduction in pharmaceutical manufacturing and safer scale-up.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Novel route for Dapoxetine HCl using chiral organocatalyst. High yield, >99% ee. Ideal for API intermediates and cost reduction in pharmaceutical manufacturing.
Patent CN106242935A reveals a green water-oil two-phase synthesis for triaryl chiral compounds. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103450073A details a novel rigid chiral catalyst synthesis offering superior stereoselectivity and cost-effective manufacturing for complex pharmaceutical intermediates.
Novel organocatalysts for asymmetric aldol reactions offering high ee/dr and recyclability for pharmaceutical intermediate manufacturing.
Patent CN115433108A details a metal-free synthesis of chiral hydrazones. This method offers high enantioselectivity and mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN102516145A reveals a novel Brønsted acid-catalyzed method for asymmetric selenofunctionalization, offering a metal-free route for high-purity pharmaceutical intermediates with simplified supply chains.
Patent CN114920702A discloses a metal-free asymmetric conjugate addition method for synthesizing optically active imidazolone compounds with high enantioselectivity and yield.
Patent CN109748883B details a metal-free asymmetric ring-opening method for high-purity chiral beta-amino derivatives, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN102766092A reveals a mild, high-enantioselective route to tetrahydroquinoline derivatives using chiral spiro phosphoric acid, offering significant cost reduction in API manufacturing.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high enantioselectivity and potent anticancer activity.
Patent CN116082217B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral bisindoles with high cytotoxic activity, offering cost-effective routes for API manufacturing.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones using chiral phosphoric acid, offering cost-effective solutions for API manufacturing.
Patent CN113980028A reveals a mild organocatalytic route for chiral spiro indolones. Discover cost-effective manufacturing and high stereoselectivity for API intermediates.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering scalable solutions for reliable pharmaceutical intermediate suppliers.
Patent CN110467555B details a chiral phosphoric acid catalyzed method for high-purity axial chiral aryl indoles, offering cost-effective routes for oncology drug development.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Novel chiral phosphoric acid catalysis enables high-yield antitumor intermediate production. Scalable process offers significant cost and supply chain advantages for global pharmaceutical partners.